Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates
US10596270B2 · kind B2 · utility
9Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2018 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Nov 4, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibody conjugates with binding specificity for folate receptor alpha (FOLR1) and its isoforms and homologs, and compositions comprising the antibody conjugates, including pharmaceutical compositions. Also provided are methods of producing the antibody conjugates and compositions as well as methods of using the antibody conjugates and compositions, such as in therapeutic and diagnostic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.